E46: Atul Rustgi of Accolade on What is LP Value-Add and Can it Lead to Alpha?

Atul Rustgi sits down with David Weisburd to discuss his role as a GP & LP, the paradoxes of selling and building relationships in VC, and the strategy of focusing on funds under $100 million. They also delve into including biotech as a diversification strategy, the importance of blockchain and crypto exposure, family office investments, and the challenges and rewards of raising a fund during a market downturn. (0:00) Episode Preview (0:45) Introduction of Guest - Atul Rustgi: Role and Responsibilities as a GP (3:30) Discussion on the Paradoxes of Selling and Relationship Building in VC (6:03) Strategy Behind Focusing on Funds Under $100 Million and the Math Behind Ownership (11:14)Biotech as a Means to Diversify and Generate Alpha in VC (16:01)Sponsor: Deel (16:43)Blockchain and Crypto: The Importance of Exposure (21:03)Family Office Direct Investments and The Value of Reference Calls (24:57)Raising a Fund During a Market Downturn: Challenges and Rewards (26:17)10X Capital Podcast Newsletter (26:42)Lessons Learned from a Long Career in Venture Capital by Atul Rustgi